Adverse events
oropharyngeal pain
ADVERSE EVENTS, GASTROESOPHAGEAL REFLUX, OCULAR HYPEREMIA
Nine of 148 (6%) subjects experienced nine adverse events during the study. Gastroesophageal reflux (one subject) and oropharyngeal pain (one subject) were each considered by the principal investigator (PI) to be possibly related and related to IP, respectively. All other adverse events were judged by the PI not to be related to IP. All adverse events were of mild intensity except for moderate ocular hyperemia in one subject, which was deemed unrelated to product use and led to subject withdrawal from the study by the PI. No serious adverse events were reported.